Physician profile
Victor King
NPI 1760483283
$344.81
in general payments reported to CMS, 2019-2025
12 companies · $111 in 2025
The $111 reported for 2025 was more than what a typical Anesthesiology provider received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $40.02 · 2021: $34.81 · 2022: $25.71 · 2023: $65.58 · 2024: $67.66 · 2025: $111.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $244.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $62.60 | 2019-2025 | Welireg, Keytruda |
| Progenics Pharmaceuticals, INC. | $42.99 | 2023-2024 | Pylarify |
| Teleflex LLC | $39.79 | 2023 | Urolift |
| Astrazeneca Pharmaceuticals Lp | $26.60 | 2024 | Lynparza |
| Takeda Pharmaceuticals U.S.A., INC. | $25.71 | 2022 | |
| Antares Pharma, INC. | $24.59 | 2025 | Xyosted, Tlando |
| Accord Healthcare, INC. | $23.86 | 2024 | |
| Sumitomo Pharma America, INC. | $23.57 | 2025 | Orgovyx |
| Olympus America INC. | $21.70 | 2025 | Itind System |
| Vertex Pharmaceuticals Incorporated | $19.98 | 2025 | |
| Acacia Pharma INC | $19.54 | 2021 | |
| Ge Healthcare | $13.88 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Victor King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.